Herbal menopause therapy a good fit for breast cancer patients?

Oct 07, 2008

When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a common drug used to treat breast cancer.

As women age and reach menopause, their risk of developing breast cancer increases. Many women who have, or are at risk, for breast cancer take tamoxifen. The drug prevents approximately 50 percent of breast cancers in women who have an increased risk of developing breast cancer. However, when women take tamoxifen, they cannot take hormone replacement therapies to relieve menopausal symptoms. Their options are limited to taking antidepressants that can have complications, enduring uncomfortable menopausal symptoms, or trying the black cohosh.

"Hopefully, this study will provide evidence that black cohosh is safe to use for breast cancer patients," said Rachel Ruhlen, a postdoctoral researcher in the MU School of Medicine. "Currently, there is little reliable information guiding women in how they can use foods and botanical supplements to enhance their treatment or improve their quality of life."

To study how black cohosh and tamoxifen interact, Ruhlen will use a group of rats prone to breast cancer, known as ACI rats. Previous studies have found that human breast cancer is associated with life-time exposure of estrogen. ACI rats, like humans, develop mammary tumors after exposure to estrogen. In a previous study, Ruhlen found that when ACI rats were treated with the human breast cancer drug tamoxifen, mammary tumor mass was reduced by 89 percent.

"Many animal models of breast cancer differ in important ways from humans with breast cancer," Ruhlen said. "These models are useful in studying how human tumors grow and spread to other parts of the body, but fall short because of the difference in how human tumors begin. However, mammary tumors in ACI rats share several key features with the majority of human breast cancers, particularly in how tumors start. Because the ACI rats develop tumors and can be treated in a way similar to humans, it is a relevant model for human breast cancer."

Source: University of Missouri-Columbia

Explore further: Green tea ingredient may target protein to kill oral cancer cells

add to favorites email to friend print save as pdf

Related Stories

Standalone wireless info display device an easy fit

1 hour ago

A Latvian team has come up with a good-looking WiFi display device, connecting to the Internet using WiFi, which runs on a high-capacity built-in battery and tracks what's important to you. This is a standalone ...

Technology improves avalanche gear for backcountry skiers

3 hours ago

As outdoor recreation companies increasingly cater to skiers and snowboarders who like to venture beyond the groomed slopes at ski resorts and tackle backcountry terrain, they've put a special emphasis on gear and equipment ...

The elephant poaching business in numbers

3 hours ago

From the pittance paid to local poachers to a multi-billion dollar industry, here are some of the key numbers related to Africa's endangered elephants:

UN moves toward major treaty for ocean biodiversity

3 hours ago

UN member states agreed Saturday to begin negotiations on a treaty to protect marine biodiversity in ocean areas extending beyond territorial waters, in a move heralded by environmental organizations.

Recommended for you

Core needle biopsy helpful with cervical lymphadenopathy

15 hours ago

(HealthDay)—Core needle biopsy (CNB) is a more sensitive tool than fine-needle aspiration cytology (FNAC) for cervical lymphadenopathy evaluation, according to a study published in the February issue of ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.